{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:31:52Z","timestamp":1793457112222,"version":"4.5.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s11102-026-01749-8","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:56:11Z","timestamp":1787230571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term endocrine outcomes of transsphenoidal surgery for prolactinomas: a 20-year single-center cohort study"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0022-6355","authenticated-orcid":false,"given":"Rom\u00e9o Bujiriri","family":"Murhega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2665-9455","authenticated-orcid":false,"given":"Stefan Matei","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9934-2024","authenticated-orcid":false,"given":"Christian","family":"Raftopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0918-637X","authenticated-orcid":false,"given":"Dominique","family":"Maiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9998-3499","authenticated-orcid":false,"given":"Edward","family":"Fomekong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"1749_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillam","year":"2006","unstructured":"Gillam MP, Molitch ME, Lombardi G, Colao A (2006) Advances in the treatment of prolactinomas. Endocr Rev 27:485\u2013534. https:\/\/doi.org\/10.1210\/er.2005-9998","journal-title":"Endocr Rev"},{"key":"1749_CR2","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"S Petersenn","year":"2023","unstructured":"Petersenn S, Fleseriu M, Casanueva FF et al (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol 19:722\u2013740. https:\/\/doi.org\/10.1038\/s41574-023-00886-5","journal-title":"Nat Rev Endocrinol"},{"key":"1749_CR3","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1210\/jc.2003-030979","volume":"89","author":"A Colao","year":"2004","unstructured":"Colao A, Vitale G, Cappabianca P et al (2004) Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. J Clin Endocrinol Metab 89:1704\u20131711. https:\/\/doi.org\/10.1210\/jc.2003-030979","journal-title":"J Clin Endocrinol Metab"},{"key":"1749_CR4","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1530\/EO-21-0038","volume":"2","author":"SMC De Sousa","year":"2022","unstructured":"De Sousa SMC (2022) Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management? Endocr Oncol 2:R31\u2013R50. https:\/\/doi.org\/10.1530\/EO-21-0038","journal-title":"Endocr Oncol"},{"key":"1749_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR et al (2011) Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:273\u2013288. https:\/\/doi.org\/10.1210\/jc.2010-1692","journal-title":"J Clin Endocrinol Metab"},{"key":"1749_CR6","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3390\/jcm14041089","volume":"14","author":"JA Mann","year":"2025","unstructured":"Mann JA, Starreveld Y, Riva-Cambrin J, Lithgow K (2025) A Narrative Review of Surgery for Prolactinomas: Considerations and Controversies. J Clin Med 14:1089. https:\/\/doi.org\/10.3390\/jcm14041089","journal-title":"J Clin Med"},{"key":"1749_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s41016-022-00277-1","volume":"8","author":"X Cai","year":"2022","unstructured":"Cai X, Zhu J, Yang J et al (2022) Are dopamine agonists still the first-choice treatment for prolactinoma in the era of endoscopy? A systematic review and meta-analysis. Chin Neurosurg J 8:9. https:\/\/doi.org\/10.1186\/s41016-022-00277-1","journal-title":"Chin Neurosurg J"},{"key":"1749_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11060-013-1270-8","volume":"117","author":"ME Molitch","year":"2014","unstructured":"Molitch ME (2014) Management of medically refractory prolactinoma. J Neurooncol 117:421\u2013428. https:\/\/doi.org\/10.1007\/s11060-013-1270-8","journal-title":"J Neurooncol"},{"key":"1749_CR9","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1530\/EJE-11-1000","volume":"166","author":"V Primeau","year":"2012","unstructured":"Primeau V, Raftopoulos C, Maiter D (2012) Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients. Eur J Endocrinol 166:779\u2013786. https:\/\/doi.org\/10.1530\/EJE-11-1000","journal-title":"Eur J Endocrinol"},{"key":"1749_CR10","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.3346\/jkms.2021.36.e97","volume":"36","author":"K Park","year":"2021","unstructured":"Park K, Park KH, Park HR et al (2021) Long-term Outcome of Microscopic Transsphenoidal Surgery for Prolactinomas as an Alternative to Dopamine Agonists. J Korean Med Sci 36:e97. https:\/\/doi.org\/10.3346\/jkms.2021.36.e97","journal-title":"J Korean Med Sci"},{"key":"1749_CR11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s42000-021-00309-y","volume":"20","author":"L Wei","year":"2021","unstructured":"Wei L, Wei X (2021) Outcomes of transsphenoidal surgery in dopamine agonist-resistant prolactinomas: a retrospective study. Horm (Athens) 20:745\u2013752. https:\/\/doi.org\/10.1007\/s42000-021-00309-y","journal-title":"Horm (Athens)"},{"key":"1749_CR12","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s40618-021-01569-6","volume":"44","author":"L Andereggen","year":"2021","unstructured":"Andereggen L, Frey J, Andres RH et al (2021) First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center. J Endocrinol Invest 44:2621\u20132633. https:\/\/doi.org\/10.1007\/s40618-021-01569-6","journal-title":"J Endocrinol Invest"},{"key":"1749_CR13","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1007\/s11102-021-01188-7","volume":"24","author":"KJ Yagnik","year":"2021","unstructured":"Yagnik KJ, Erickson D, Bancos I et al (2021) Surgical outcomes of medically failed prolactinomas: a systematic review and meta-analysis. Pituitary 24:978\u2013988. https:\/\/doi.org\/10.1007\/s11102-021-01188-7","journal-title":"Pituitary"},{"key":"1749_CR14","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310:2191\u20132194. https:\/\/doi.org\/10.1001\/jama.2013.281053","journal-title":"JAMA"},{"key":"1749_CR15","doi-asserted-by":"publisher","first-page":"e4242","DOI":"10.1210\/clinem\/dgaf355","volume":"110","author":"ME Molitch","year":"2025","unstructured":"Molitch ME, Mamelak AN (2025) Debate: Surgery as initial therapy for microprolactinoma. J Clin Endocrinol Metab 110:e4242\u2013e4247. https:\/\/doi.org\/10.1210\/clinem\/dgaf355","journal-title":"J Clin Endocrinol Metab"},{"key":"1749_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ando.2021.11.008","volume":"83","author":"H Lasolle","year":"2022","unstructured":"Lasolle H, Teulade M, Lapras V et al (2022) Postoperative remission of non-invasive lactotroph pituitary tumor: A single-center experience. Ann d\u2019Endocrinologie 83:1\u20138. https:\/\/doi.org\/10.1016\/j.ando.2021.11.008","journal-title":"Ann d\u2019Endocrinologie"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01749-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01749-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01749-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:12:01Z","timestamp":1793455921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01749-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1749"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01749-8","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"14 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Hospital-Faculty Ethics Committee of the Cliniques universitaires Saint-Luc, Brussels, Belgium (CEHF reference 2015\/293; approval date: June 15, 2015).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"145"}}